Regencell Bioscience Holdings income statement data for the quarter ended Dec 2025. This income statement covers 7 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2020 | Jun2021 | Jun2022 | Jun2023 | Jun2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|
| Additional items | |||||||
| Shares Outstanding | 10.00M | 10.00M | 12.81M | 13.01M | 13.01M | 13.01M | 13.01M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 10.00M | 10.00M | 12.81M | 13.01M | 13.01M | 13.01M | 13.01M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 10.00M | 10.00M | 13.01M | 13.01M | 13.01M |